...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Sincerely,

George et al

Message: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
Reply New Message
Prev Message Back To Forum Threaded View Next Message

I have almost become immune to hope in the current retail market haha ... until official word from the FDA regarding path forward, Nasdaq (legitimacy & market), or a significant BP partner/buyer.  

I DO believe this to be a winner "eventuallly" though at some point (4-36 months?). So, not looking to be negative, just pragmatic. Would love to be wrong, and see the pps ttake off prior to the above mentioned issues & opportunities.

Hoping for GREAT Cognitive data, to go with the other previously disclosed excellent data to keep things moving forward on all fronts, and hopefully a mild-moderate effect on the pps, while waiting for "other" news and milestones. 

All speculation and jmho's of course

6 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply